Key Events Drive Significant Portion of Association Between Depression, Healthcare Utilization and Cost

July 17, 2020

Patients with major depressive disorder have higher healthcare utilization rates when they experience certain key clinical events, according to a new study.

Boosting Molecular Testing in Patients with GIST Would Have Minimal Cost Impact, Study Finds

July 06, 2020

Researchers cost-impact model calculates the cost to be 15 centers PMPY.

Patients with HCC Shoulder Economic Burdens, Have Insufficient Therapeutic Options, Studies Find

June 16, 2020

Cases of the most common type of liver cancer are expected to be increasingly associated with nonalcoholic steatohepatitits (NASH).

ICER Reports Play Significant Role in Managed Care’s Decision-Making, Study Finds

June 16, 2020

The Institute for Clinical and Economic Review appears to be an important source of information for managed care executives making decisions about treatment and cost.

Claim Analysis By Specialty Pharmacist Saves Health Plan $2.7 Million, Study Finds

May 20, 2020

A new study highlights the role a qualified specialty pharmacist can play in driving down costs across a health plan.

Adherence to Disease-Modifying Drugs Lowers Chronic Opioid Use in Patients with Inflammatory Conditions

May 19, 2020

A study of patients with inflammatory conditions who were prescribed biologic disease-modifying anti-rheumatic drugs had lower rates of chronic opioid use if they were adherent to their biologic therapy, according to new research.

Breakthrough Therapies, Opportunities for Savings in Near-term Specialty Pipeline

November 21, 2019

As more competition makes its way into the specialty drug market, there will be opportunities for cost savings.

AMCP NEXUS 2019 Street Team: Susan Trieu of MedImpact Healthcare Systems, Inc.

November 01, 2019

At AMCP NEXUS 2019, Susan Trieu, PharmD, director of Enterprise Specialty Clinical Solutions for MedImpact Healthcare Systems, Inc, predicts the top specialty drug categories that will be driving spend in 2020.

The Rise of Specialty Spend

October 26, 2019

How can payers appropriately plan and manage benefit coverage with so many expensive specialty drugs coming down the pipeline?

Preparing for Biosimilar Uptake

October 25, 2019

As more biosimilar drugs gain approval, managed care organizations need to consider how to best utilize them for optimal savings.

Embracing Value-Based Outcomes Management

October 25, 2019

As more of the healthcare industry moves to value-based contracts, it is imperative that managed care organizations can successfully measure outcomes.

Legislating Medicare and Medicaid Drug Plans

October 25, 2019

With the proposed rebate rule now withdrawn, what will Congress do to help curb drug spend?

A Brave New World of Health Technology and Digital Therapeutics

October 19, 2019

As digital health and therapeutic capabilities continue to grow, it is vital that managed care organizations keep one eye toward the future.

Three Ways One Health Plan Increased Biosimilar Uptake

October 26, 2018

Biosimilars hold great cost savings promises for payers and patients alike-but only if prescribers and patients are willing to make the switch.

Top 4 Ways Healthcare Executives Can Be Better Leaders

October 26, 2018

Good leaders don’t just rely on one managerial style-they get the best out of every team member by meeting their needs.